| Dr Elizabeth C Dodd, DO | |
|
910 W 10th St, Rolla, MO 65409-1131 | |
| (573) 341-4284 | |
| Not Available |
| Full Name | Dr Elizabeth C Dodd |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 910 W 10th St, Rolla, Missouri |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538301155 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | R9349 (Texas) | Secondary |
| 208000000X | Pediatrics | 2021034963 (Missouri) | Primary |
| Entity Name | Advocates For A Healthy Community Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558303057 PECOS PAC ID: 5395653562 Enrollment ID: O20041109000631 |
News Archive
Treatments that ramp up production of the tiny "motors" that power cells may have promise for treating one of the most common forms of inherited neuromuscular disease, according to a report in the September Cell Metabolism, a Cell Press publication. Neuromuscular disorders caused by defects in those mitochondrial motors affect a large number of children and adults worldwide, but today remain without treatment, the researchers said.
Funded by the European Union, MoniQA (Monitoring and Quality Assurance in the total food supply chain) involves experts from around the globe collaborating to harmonise worldwide food quality and safety monitoring and control strategies. The project has developed a database of food quality and safety issues and corresponding analytical tools for food production and the supply chain.
Timing may be decisive when it comes to overcoming cancer's ability to evade treatment. By hitting breast cancer cells with a targeted therapeutic immediately after chemotherapy, researchers from Brigham and Women's Hospital (BWH) were able to target cancer cells during a transitional stage when they were most vulnerable, killing cells and shrinking tumors in the lab and in pre-clinical models.
Targeted cancer cell therapies using man-made proteins dramatically shrink many tumors in the first few months of treatment, but new research from Johns Hopkins scientists finds why the cells all too often become resistant, the treatment stops working, and the disease returns.
Pregnant women with a short cervix who used a small silicone ring called a cervical pessary to keep their cervix closed had a lower rate of preterm birth at less than 34 weeks.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Elizabeth C Dodd, DO 910 W 10th St, Rolla, MO 65409-6519 Ph: (573) 341-4284 | Dr Elizabeth C Dodd, DO 910 W 10th St, Rolla, MO 65409-1131 Ph: (573) 341-4284 |
News Archive
Treatments that ramp up production of the tiny "motors" that power cells may have promise for treating one of the most common forms of inherited neuromuscular disease, according to a report in the September Cell Metabolism, a Cell Press publication. Neuromuscular disorders caused by defects in those mitochondrial motors affect a large number of children and adults worldwide, but today remain without treatment, the researchers said.
Funded by the European Union, MoniQA (Monitoring and Quality Assurance in the total food supply chain) involves experts from around the globe collaborating to harmonise worldwide food quality and safety monitoring and control strategies. The project has developed a database of food quality and safety issues and corresponding analytical tools for food production and the supply chain.
Timing may be decisive when it comes to overcoming cancer's ability to evade treatment. By hitting breast cancer cells with a targeted therapeutic immediately after chemotherapy, researchers from Brigham and Women's Hospital (BWH) were able to target cancer cells during a transitional stage when they were most vulnerable, killing cells and shrinking tumors in the lab and in pre-clinical models.
Targeted cancer cell therapies using man-made proteins dramatically shrink many tumors in the first few months of treatment, but new research from Johns Hopkins scientists finds why the cells all too often become resistant, the treatment stops working, and the disease returns.
Pregnant women with a short cervix who used a small silicone ring called a cervical pessary to keep their cervix closed had a lower rate of preterm birth at less than 34 weeks.
› Verified 8 days ago
Katherine Sue Cook, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 700 W 11th St, Rolla, MO 65401 Phone: 573-364-1900 Fax: 573-364-7365 | |
James T Burdett, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1050 W 10th St, Rolla, MO 65401 Phone: 573-364-9000 Fax: 573-426-6694 | |
Patricia Kelley Deforest, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 1050 W 10th St, Rolla, MO 65401 Phone: 573-426-3225 Fax: 573-202-2444 | |
Shawna C Gifford, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1050 W 10th St, Rolla, MO 65401 Phone: 573-364-9000 Fax: 573-426-3643 | |
Jonathan Lee Minor, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 910 W 10th St, Rolla, MO 65409 Phone: 573-342-4284 Fax: 573-341-6967 | |
Dr. Sean A. Mcenaney, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1100 W 10th St, Suite 175, Rolla, MO 65401 Phone: 573-341-9163 Fax: 573-368-4248 |